Quest Diagnostics (DGX) Tops Q4 EPS by 4c; offers guidance
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $197.18 +1.86%
EPS Growth %: +7.6%
Financial Fact:
Income tax expense: -95M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +7.6%
Financial Fact:
Income tax expense: -95M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $2.23, $0.04 better than the analyst estimate of $2.19. Revenue for the quarter came in at $2.62 billion versus the consensus estimate of $2.58 billion.
GUIDANCE:
Quest Diagnostics sees FY2025 EPS of $9.55-$9.80, versus the consensus of $9.72. Quest Diagnostics sees FY2025 revenue of $10.7-10.85 billion, versus the consensus of $10.671 billion.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
- Enanta Pharma loses appeal in Pfizer Paxlovid patent case
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
